HomeCompareDNBBY vs MRK

DNBBY vs MRK: Dividend Comparison 2026

DNBBY yields 6.03% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DNBBY wins by $18121.31M in total portfolio value
10 years
DNBBY
DNBBY
● Live price
6.03%
Share price
$31.36
Annual div
$1.89
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18121.36M
Annual income
$17,561,586,027.00
Full DNBBY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — DNBBY vs MRK

📍 DNBBY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDNBBYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DNBBY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DNBBY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DNBBY
Annual income on $10K today (after 15% tax)
$512.28/yr
After 10yr DRIP, annual income (after tax)
$14,927,348,122.95/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, DNBBY beats the other by $14,927,339,794.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DNBBY + MRK for your $10,000?

DNBBY: 50%MRK: 50%
100% MRK50/50100% DNBBY
Portfolio after 10yr
$9060.71M
Annual income
$8,780,797,912.57/yr
Blended yield
96.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

DNBBY
Analyst Ratings
3
Buy
2
Hold
3
Sell
Consensus: Buy
Altman Z
-0.4
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DNBBY buys
1
MRK buys
0
PoliticianChamberTickerTypeAmountDate
Daniel Goldman🏢 House$DNBBY▼ Sell$15,001 - $50,0002023-07-10
Daniel Goldman🏢 House$DNBBY▼ Sell$15,001 - $50,0002023-03-31
John Rutherford🏢 House$DNBBY▼ Sell$1,001 - $15,0002022-03-16
John Rutherford🏢 House$DNBBY▲ Buy$1,001 - $15,0002022-02-17
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDNBBYMRK
Forward yield6.03%2.76%
Annual dividend / share$1.89$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$18121.36M$56.8K
Annual income after 10y$17,561,586,027.00$9,798.13
Total dividends collected$18082.58M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: DNBBY vs MRK ($10,000, DRIP)

YearDNBBY PortfolioDNBBY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,905$1,205.36$11,206$366.19+$699.00DNBBY
2$15,421$2,682.28$12,650$502.35+$2.8KDNBBY
3$22,995$6,494.13$14,407$694.19+$8.6KDNBBY
4$42,704$18,100.08$16,585$967.82+$26.1KDNBBY
5$108,524$62,830.78$19,342$1,363.89+$89.2KDNBBY
6$414,573$298,451.84$22,913$1,947.19+$391.7KDNBBY
7$2,574,645$2,131,051.88$27,662$2,823.89+$2.55MDNBBY
8$27,492,416$24,737,546.14$34,159$4,173.35+$27.46MDNBBY
9$523,156,985$493,740,099.16$43,337$6,308.80+$523.11MDNBBY
10$18,121,364,000$17,561,586,027.00$56,776$9,798.13+$18121.31MDNBBY

DNBBY vs MRK: Complete Analysis 2026

DNBBYStock

DNB Bank ASA provides financial services for retail and corporate customers in Norway and internationally. The company offers personal banking products and services, including savings and investment products; loans, such as home mortgages, and car and consumer loans; pet, home and property, travel, and personal insurance products, as well as insurance products for vehicles; retirement savings products; foreign exchange and treasury activities; and Internet and mobile banking services, as well as cards. It also provides business banking products and services comprising savings and investment products consisting of savings accounts, fixed rate deposits, exchange traded products, bonds and commercial papers, asset management, and equity services; financing, such as installment loans, overdraft facility, bank guarantees, leasing, factoring, and trade and export financing services; transaction banking services; research, commodities, bonds and commercial papers, corporate finance, debt capital market, equities, foreign exchange and interest rates, and securities services; and Internet services, including online equity trading, online FX trading, e-confirmation, equities execution, and investor and margin accounts, as well as pension services. In addition, the company provides investment banking services, such as mergers and acquisition, and equity and debt capital market services; foreign exchange, interest rates, equities, commodities, fixed income, research, private equity, and securities services; and corporate banking services. Further, it offers private banking services. The company offers its products and services to various sectors, including energy; financial institutions; healthcare; manufacturing; packaging and forest products; seafood; shipping, offshore, and logistics; and telecom, media, and technology. DNB Bank ASA was founded in 1822 and is headquartered in Oslo, Norway.

Full DNBBY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this DNBBY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DNBBY vs SCHDDNBBY vs JEPIDNBBY vs ODNBBY vs KODNBBY vs MAINDNBBY vs JNJDNBBY vs ABBVDNBBY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.